Equillium, Inc. - Common Stock — Balance Sheet (NASDAQ:EQ) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Total assets 85.43 M85.41 M78.42 M50.53 M25.6 M31.89 M Total liabilities 15.57 M18.9 M46.48 M27.96 M6.54 M3.29 M Total equity 69.85 M66.5 M31.94 M22.57 M19.06 M28.6 M Total liabilities & shareholders' equities 85.43 M85.41 M78.42 M50.53 M25.6 M31.89 M Total debt 8.28 M8.75 M3.24 M——— Net debt -73.92 M-71.95 M-67.76 M———

News

Forte Biosciences: 2026 Is Major Inflection Point For FB102 (NASDAQ:FBRX)

Equillium (EQ) SVP Zedelmayer sells $300k in shares

Equillium secures $35M financing from RA Capital Management

Roth/MKM initiates Equillium stock with buy on ulcerative colitis drug

Equillium SVP Zedelmayer sells $328k in shares

Stifel initiates Equillium stock with buy rating on IBD potential

Equillium principal accounting officer Tom Penny sells $8427 in stock

Equillium SVP Zedelmayer sells $7.7k in stock

The Zacks Analyst Blog Highlights MS, VOO, SPY, IVV, SPYM, RSP, EQ and EQWL

Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases - Slideshow (NASDAQ:EQ) 2025-11-09

Equillium announces leadership changes as it shifts focus to EQ504

Equillium files prospectus supplement for up to $75 million stock offering